M
Maxime Dougados
Researcher at University of Paris
Publications - 1144
Citations - 78022
Maxime Dougados is an academic researcher from University of Paris. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 134, co-authored 1054 publications receiving 69979 citations. Previous affiliations of Maxime Dougados include French Institute of Health and Medical Research & Paris Descartes University.
Papers
More filters
Journal Article
Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.
Damini Jawaheer,Jørn Olsen,Maureen Lahiff,Sinikka Forsberg,Jukka Lähteenmäki,Inês Guimarães da Silveira,Francisco Airton Castro Rocha,Ieda Maria Magalhães Laurindo,Licia Maria Henrique da Mota,Alexandros A. Drosos,Eithne Murphy,C. Sheehy,Edel Quirke,Maurizio Cutolo,Sylejman Rexhepi,J. Dadoniene,S. M. M. Verstappen,Tuulikki Sokka,Sergio Toloza,Santiago Aguero,Sergio Orellana Barrera,Soledad Retamozo,Paula Alba,Cruz Lascano,Alejandra Babini,Eduardo Albiero,Geraldo da Rocha Castelar Pinheiro,Juris Lazovskis,Merete Lund Hetland,Lykke Midtbøll Ørnbjerg,Kim Hørslev-Petersen,T M Hansen,Lene Surland Knudsen,Hisham Hamoud,Mohamad Sobhy,Ahmad Mahmoud Ahmed Mohamed Fahmy,Mohamad Magdy,Hany Aly,Hatem Saeid,Ahmad Nagm,Nihal A. Fathi,Esam Abda,Zahra Ebraheam,Raili Müller,Reet Kuuse,Marika Tammaru,Riina Kallikorm,Tony Peets,Kati Otsa,Karin Laas,Ivo Valter,Heidi Mäkinen,Kai Immonen,Reijo Luukkainen,Laure Gossec,Maxime Dougados,Jean Francis Maillefert,Bernard Combe,Jean Sibilia,Sofia A Exarchou,Haralampos M. Moutsopoulos,Afrodite K. Tsirogianni,Fotini N. Skopouli,Maria Mavrommati,G. Herborn,Rolf Rau,Rieke Alten,Christof Pohl,Gerd R Burmester,Bettina Marsmann,Pál Géher,Bernadette Rojkovich,Barry Bresnihan,Patricia Minnock,Joe Devlin,Shafeeq Alraqi,Amita Aggarwal,Sapan Pandya,Banwari Sharma,M Cazzato,Stefano Bombardieri,Gianfranco Ferraccioli,Alessia Morelli,Fausto Salaffi,Andrea Stancati,Hisashi Yamanaka,Ayako Nakajima,Wataru Fukuda,Eisuke Shono,Omondi Oyoo,Mjellma Rexhepi,Daina Andersone,Sigita Stropuviene,Asta Baranauskaite,Naija Hajjaj-Hassouni,Karima Benbouazza,Fadoua Allali,Rachid Bahiri,Bouchra Amine,Johannes W G Jacobs,Margriet Huisman,Monique Hoekstra,Glenn Haugeberg,Hilde Gjelberg,Stanisław Sierakowski,Maria Majdan,Wojciech Romanowski,Witold Tłustochowicz,Danuta Kapolka,Stefan Sadkiewicz,Danuta Zarowny-Wierzbinska,Ruxandra Ionescu,Denisa Predeteanu,Dmitry Karateev,E. L. Luchikhina,Natalia Chichasova,Vladimir Badokin,Vlado Skakic,Aleksander Dimic,Jovan Nedovic,Aleksandra Stanković,Antonio Naranjo,Carlos Rodríguez-Lozano,Jaime Calvo-Alén,Miguel Belmonte,Eva Baecklund,Dan Henrohn,Rolf Oding,Margareth Liveborn,Ann Carin Holmqvist,Feride Gogus,Recep Tunc,Selda Celic,Humeira Badsha,Ayman Mofti,Peter C. Taylor,C McClinton,Anthony D. Woolf,Ginny Chorghade,Ernest Choy,Stephen Kelly,Theodore Pincus,Theodore Pincus,Yusuf Yazici,Martin J. Bergman,Jurgen Craig-Muller,Hannu Kautiainen,Christopher J. Swearingen +147 more
TL;DR: Overall, women were younger, had longer disease duration, and higher DAS28 scores than men, but BMI was similar between genders, compared to the normal BMI range.
Journal ArticleDOI
When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
TL;DR: Patient numbers are small and firm conclusions cannot be reached, but a non-significant benefit is indicated for combining leflunomide with sulfasalazine compared with switching to sulfAsalazine alone in patients inadequately responding to leflinomide.
Journal ArticleDOI
Classification criteria for rheumatic diseases: Why and how?
Maxime Dougados,Laure Gossec +1 more
TL;DR: A basis for recommendations and procedures proposed by the ACR Classification and Response Criteria Subcom-mittee with regard to the elaboration and validation steps of criteria for rheu-matic diseases has been explicitly described in the article by Johnson et al.
Journal ArticleDOI
Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology
Daniel Wendling,Maxime Dougados,Francis Berenbaum,Olivier Brocq,Thierry Schaeverbeke,Bernard Mazières,Christian Marcelli,Jean-Marie LePARC,Philippe Bertin,Michèle Robin,Jean Sibilia,P. Lafforgue,Clément Prati,Bernard Combe,Jacques-Eric Gottenberg +14 more
TL;DR: In this nationwide study of several subsets of SpA, RTX had only a moderate efficacy that was more marked in patients who were anti-TNF-naive, and no predictive factors of response could be identified, particularly in diagnosis subsets or clinical presentation.
Journal ArticleDOI
Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis
Alexandre Sepriano,Robert Landewé,Désirée van der Heijde,Joachim Sieper,Nurullah Akkoc,J. Brandt,Jürgen Braun,Eduardo Collantes-Estevez,Maxime Dougados,Oliver FitzGerald,Feng Huang,Jieruo Gu,Yesim Kirazli,Walter P. Maksymowych,Helena Marzo-Ortega,Ignazio Olivieri,Salih Ozgocmen,Euthalia Roussou,Salvatore Scarpato,Inge Juul Sørensen,Inge Juul Sørensen,Rafael Valle-Oñate,Filip Van den Bosch,Irene E. van der Horst-Bruinsma,Ulrich Weber,James Cheng-Chung Wei,Martin Rudwaleit +26 more
TL;DR: The positive predictive value (PPV) of the baseline classification by the ASAS criteria to forecast an expert's diagnosis of ‘SpA’ after more than 4 years is excellent and the ‘imaging arm’ and ‘clinical arm” of the axSpA criteria have similar predictive validity and are truly complementary.